Eric Poma
Board of Directors
Molecular Templates
United States of America
Biography
Eric E. Poma, Ph.D. has served as a member of MTEM’s Board of Directors since founding MTEM in February 2009. Since 2009, Dr. Poma has served as the Chief Executive Officer and Chief Scientific Officer of MTEM From March 2005 until September 2008, Dr. Poma was Vice President of Business Development of Innovive Pharmaceuticals (acquired by Cytrx Corporation), a biotechnology company. From 2001 to 2005, he served as the Associate Vice President of Business Development at ImClone Systems, Inc.(now Eli Lilly and Company) a biotechnology company focused on antibody therapeutics. As the founder and in his role as Chief Scientific Officer at MTEM, he led the invention of technology underlying MTEM’s platform technology and what constitutes the whole of MTEM’s current lead and preclinical pipeline candidates. Dr. Poma received his Ph.D. in Microbiology and Immunology and B.A. in Biology and from the University of North Carolina at Chapel Hill and his M.B.A. from New York University.
Research Interest
Microbiology and Immunology
